Drugmakers
-
{
- All
- News
-
Positive Results For Potential First Chikungunya Vaccine
French-Austrian drugmaker Valneva's vaccine candidate against chikungunya, a mosquito-borne virus that causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday.
-
Five Indian Drugmakers To Jointly Start Trial Of Merck & Co's Covid Drug
Fivegeneric drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in the country.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Trump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price Hikes
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.
-
Donald Trump Vows To Bring Down Drug Prices, Doesn't Say How
President-elect Donald Trump took aim at drugmakers on Wednesday by promising in a magazine interview that "I'm going to bring down drug prices," sending shares of pharmaceutical and biotechnology companies lower.
-
Indian Pharma Tycoons Foray Into New Drugs To Shore Up Growth
Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs.
-
Drug Industry To Fight Superbugs Together With Governments
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and poor.
-
Report: US Drug Maker Was Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, US Senate investigators said Tuesday.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Tekmira Begins Limited Manufacturing of Drug Targeting Ebola
Canadian drugmaker Tekmira Pharmaceuticals Corp has begun limited manufacturing of a drug targeting the Ebola-Guinea virus that has killed more than 4,500 people, mostly in West Africa.
-
Diabetes drug maker hid test data on risks, files indicate
In the fall of 1999, the drug giant SmithKline Beecham secretly began a study to find out if its diabetes medicine, Avandia, was safer for the heart than a competing pill, Actos, made by Takeda. Avandia's success was crucial to SmithKline, whose labs were otherwise all but barren of new products. But the study's results, completed that same year, w...
-
Positive Results For Potential First Chikungunya Vaccine
French-Austrian drugmaker Valneva's vaccine candidate against chikungunya, a mosquito-borne virus that causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday.
-
Five Indian Drugmakers To Jointly Start Trial Of Merck & Co's Covid Drug
Fivegeneric drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in the country.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Trump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price Hikes
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.
-
Donald Trump Vows To Bring Down Drug Prices, Doesn't Say How
President-elect Donald Trump took aim at drugmakers on Wednesday by promising in a magazine interview that "I'm going to bring down drug prices," sending shares of pharmaceutical and biotechnology companies lower.
-
Indian Pharma Tycoons Foray Into New Drugs To Shore Up Growth
Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs.
-
Drug Industry To Fight Superbugs Together With Governments
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and poor.
-
Report: US Drug Maker Was Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, US Senate investigators said Tuesday.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Tekmira Begins Limited Manufacturing of Drug Targeting Ebola
Canadian drugmaker Tekmira Pharmaceuticals Corp has begun limited manufacturing of a drug targeting the Ebola-Guinea virus that has killed more than 4,500 people, mostly in West Africa.
-
Diabetes drug maker hid test data on risks, files indicate
In the fall of 1999, the drug giant SmithKline Beecham secretly began a study to find out if its diabetes medicine, Avandia, was safer for the heart than a competing pill, Actos, made by Takeda. Avandia's success was crucial to SmithKline, whose labs were otherwise all but barren of new products. But the study's results, completed that same year, w...
